NEW YORK, Aug 16 – NeoGenesis Drug Discovery has announced a deal to work with Mitsubishi-Tokyo Pharmaceuticals to identify small-molecule drug candidates. 

Under the terms of the deal, NeoGenesis of Cambridge, Mass., will use its genomics technologies to identify proteins that can be used as therapeutics. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.